McKesson Profit Margin 2010-2025 | MCK

Current and historical gross margin, operating margin and net profit margin for McKesson (MCK) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. McKesson net profit margin as of March 31, 2025 is 0.92%.
McKesson Annual Profit Margins
McKesson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $88.981B $359.051B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $50.251B 12.44
Cardinal Health (CAH) United States $37.849B 19.82
Straumann Holding AG (SAUHY) Switzerland $21.000B 0.00
West Pharmaceutical Services (WST) United States $15.093B 31.64
Cooper (COO) United States $14.263B 18.38
Align Technology (ALGN) United States $13.701B 27.20
Henry Schein (HSIC) United States $8.407B 14.42
Merit Medical Systems (MMSI) United States $4.964B 24.00
DENTSPLY SIRONA (XRAY) United States $3.115B 9.30
CONMED (CNMD) United States $1.480B 11.07
STAAR Surgical (STAA) United States $0.880B 0.00
Lifevantage (LFVN) United States $0.159B 16.36
Pro-Dex (PDEX) United States $0.152B 16.66